NCT04058756 2025-10-07Rollover Study for Continued Safety and Tolerability in Subjects Treated With Spartalizumab Alone or in Combination With Other Study TreatmentsNovartisPhase 1 Active not recruiting120 enrolled
NCT03034304 2025-07-24A Phase I Clinical Study for Evaluating the Safety and Efficacy of MASCT-I in Patients With Advanced Solid TumorsHRYZ Biotech Co.Phase 1 Terminated105 enrolled